United States: U.S. Supreme Court Reverses California's Sliding Scale Approach To Specific Personal Jurisdiction

Key Points

  • In Bristol-Myers Squibb Co. v. Superior Court of California, the U.S. Supreme Court rejected the California Supreme Court's "sliding scale" approach to specific personal jurisdiction, instead requiring plaintiffs to show that there is some connection between the forum and the underlying controversy for each plaintiff in a mass action.
  • Litigants should not conflate the tests of general and specific personal jurisdiction and should independently address each basis for personal jurisdiction.
  • Attorneys seeking a forum for mass actions will often be limited to filing claims in defendants' home jurisdictions, where courts can hear cases under general personal jurisdiction.


On June 19, 2017, in Bristol-Myers Squibb Co. v. Superior Court of California, the Supreme Court held, by a vote of 8 to 1, that California courts lack specific jurisdiction to entertain a nonresident's claims that are unrelated to any contacts the defendant has with California.  The case involved a group of plaintiffs who sued Bristol-Myers Squibb Company (BMS) in California state court, alleging that the pharmaceutical company's drug Plavix harmed them. Of the 678 plaintiffs, only 86 were residents of California. BMS is incorporated in Delaware and headquartered in New York and maintains substantial operations in both New York and New Jersey. Although BMS engages in business activities in California and sells Plavix in the state, BMS did not develop, create a marketing strategy for, manufacturer, label, package or work on the regulatory approval for Plavix in California. The nonresident plaintiffs did not allege that they were injured or treated for their injuries in California, nor did they allege that they obtained Plavix from a California source.

The California trial court concluded that BMS's extensive activities in California gave the California courts general jurisdiction. Following the Supreme Court's decision in Daimler AG v. Bauman, the California Court of Appeal disagreed, finding that California courts lacked general jurisdiction over the case. The Court of Appeal found, however, that the trial court could exercise specific jurisdiction over the plaintiffs' claims. The California Supreme Court affirmed, applying a "sliding scale approach" to specific jurisdiction and concluding that, because BMS had "wide ranging" contacts with California, there was sufficient support for a finding of specific jurisdiction over the claims brought by nonresident plaintiffs. In particular, the California Supreme Court reasoned that, because the California plaintiffs purchased Plavix in California and the claims of the nonresident plaintiffs were identical to those of the California plaintiffs, California courts had specific jurisdiction over the nonresident claims as well. The California Supreme Court also found it significant that five of BMS's research and laboratory facilities are in California, that BMS employs hundreds of sales representatives in California, and that BMS maintains a small state-government advocacy office in Sacramento.


The U.S. Supreme Court granted certiorari and reversed. The Supreme Court held that the California Supreme Court's broad conception of specific personal jurisdiction violated the Due Process Clause of the 14th Amendment. The Court first outlined the two types of personal jurisdiction: general and specific. For general jurisdiction, the forum for a corporation is "an equivalent place [of domicile], one in which the corporation is fairly regarded as at home." Specific jurisdiction, on the other hand, requires that the suit arise out of, or relate to, the defendant's contacts with the forum state.

Observing that the doctrine of personal jurisdiction serves multiple interests, including fairness to defendants and the extent of an individual state's sovereign power to try cases in their courts, the Supreme Court rejected the California Supreme Court's "sliding scale" approach to specific personal jurisdiction. In addition to due process/fairness and federalism principles, the Court relied on past precedent. Its prior cases, the Court reasoned, do not support the California Supreme Court's approach, "which resembles a loose and spurious form of general jurisdiction." The Court reiterated that a defendant's general connections with a forum are insufficient for purposes of specific personal jurisdiction, opining that "[t]he mere fact that other [California] plaintiffs were prescribed, obtained, and ingested Plavix in California—and allegedly sustained the same injuries as did the non-residents—does not allow the State to assert specific jurisdiction over nonresidents' claims." Rather, the Court found, "[w]hat is needed—and what is missing here—is a connection between the forum and the specific claims at issue." Responding to Justice Sotomayor's principal concern in her lone dissent, the Court reasoned that the decision does not prevent the California and out-of-state plaintiffs from joining together in a consolidated action in the states that have general jurisdiction over BMS.

The Court's decision left open two questions: first, whether federal courts would likewise lack personal jurisdiction given similar facts under the Fifth Amendment; and second (at least according to the dissent), whether the same conclusion would apply to a class action in which a named plaintiff resident of the forum state seeks to represent a nationwide class of plaintiffs, not all of whom were injured there.

Bottom Line:

The Supreme Court's decision in Bristol-Myers Squibb Co. marks yet another victory for defendants seeking to curb the consolidation of lawsuits in plaintiff-friendly forums. The Court made clear that the exercise of specific jurisdiction requires that the underlying controversy have some connection to the defendant's contacts with the forum state, and that courts may not utilize a "sliding scale approach" to determining whether a defendant's contacts are sufficient. In light of that holding, plaintiffs may be compelled to rely on general jurisdiction in order to sue large corporate defendants. Since general jurisdiction is available only where the defendant is incorporated or headquartered, the Court's decision significantly limits plaintiff attorneys' ability to forum shop, to the advantage of defendants.

Another consequence of the Court's decision may be that plaintiffs choose to forgo large mass actions outside of the defendant's home state in favor of multiple smaller actions in states where specific jurisdiction can be established. This too benefits defendants: when mass tort actions are smaller, defendants can focus their strategies on fewer plaintiffs and require each individual plaintiff to prove their individual claims. Given that the case was heard after the confirmation of Justice Neil Gorsuch and decided nearly unanimously, it seems unlikely that the trend toward greater due process protections for defendants will change any time in the foreseeable future.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.